Electrical impedance scanning: A new approach to skin cancer diagnosis

Skin Research and Technology

Volumn 9, Issue 3, 2003, Pages 262-268

  Glickman, Yaël A ^a   Filo, Orna ^a   David, Magda ^b   Yayon, Avner ^b   Topaz, Moris ^c   Zamir, Bosmat ^d   Ginzburg, Alexander ^e   Rozenman, Dganit ^f   Kenan, Gad ^a  

^a TransScan Medical Ltd   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c HILLEL YAFFE MEDICAL CENTER   (Israel)

^d Ibn Sina Clinic   (Israel)

^e Dermatology Clinic   (Israel)

^f HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Conductivity; Electrical impedance scanning; Melanoma; Pigmented lesion; Skin cancer

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; ELECTRIC CAPACITANCE; ELECTRIC CONDUCTIVITY; ELECTRICAL PARAMETERS; EXCISION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROMORPHOLOGY; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUDE MOUSE; PHYSICIAN; RECORDING; SENSITIVITY AND SPECIFICITY; SKIN CANCER; SKIN CONDUCTANCE; SKIN DEFECT; SKIN NECROSIS; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; ELECTRIC CAPACITANCE; ELECTRIC IMPEDANCE; ELECTRODIAGNOSIS; GALVANIC SKIN RESPONSE; HUMANS; MELANOMA; MICE; MICE, NUDE; NECROSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0042565831     PISSN: 0909752X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0846.2003.00022.x     Document Type: Article

References (37)

1. Balch CM, Houghton AN, Sober AJ, Soong SJ. Cutaneous Melanoma. Saint-Louis: Quality Medical Publishing Inc., 1998; 12-49.
2. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. Philadelphia: J B Lippincott Company, 1990; 756-805.
3. Brown N. Exploration of diagnostic techniques for malignant melanoma: an integrative review. Clin Excell Nurse Pract 2000; 4: 263-271.
4. Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented lesions. J Am Acad Dermatol 200l; 44: 979-986.
5. Ercal F, Chawla A, Stoecker WV, Lee HC, Moss RH. Neural network diagnosis of malignant melanoma from color images. IEEE Trans Biomed Engng 1994; 41: 837-845.
6. Andreassi L, Perotti R, Rubegni P, Burroni M, Cevenini G, Biagioli M, Taddeucci P, Dell'Eva G, Barbini P. Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma - A new quantitative semiology. Arch Dermatol 1999; 135: 1459-1465.
7. Elbaum M, Kopf AW, Rabinovitz HS et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol 2001; 44: 207-218.
8. Wolff K. Why is epiluminescence microscopy important? Recent Results Cancer Res 2002; 160: 125-132.
9. Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions - a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2: 443-449.
10. Reinhold U. Cutaneous malignant melanoma: from early diagnosis to gene therapy. Bull Mem Acad R Med Belg 2001; 156: 212-218.
11. Kenet RO, Kenet BJ. Risk stratification. A practical approach to using epiluminescence microscopy/dermoscopy in melanoma screening. Dermatol Clin 2001; 19: 327-335.
12. Foster KR, Schwann HP. Dielectric properties of tissues and biological materials: a critical review. Crit Rev Biomed Eng 1989; 17: 25-104.
13. Morimoto T, Kimura S, Yasunori K, Komaki K, Uyama T, Monden Y, Kinouchi Y, Iritani T. A study of the bio-electrical impedance of tumors. J Invest Surg 1993; 6: 25-32.
14. Surowiec AJ, Stuchly SSS. Electrical properties of breast carcinoma and surrounding tissues. IEEE Trans Biomed Engng 1988; 35: 257-263.
15. Jossinet J. Variability of impedivity in normal and pathological breast tissue. Med Biol Eng Comput 1996; 34: 346-350.
16. Jossinet J. The impedivity of freshly excised human breast tissue. Physiol Meas 1998; 19: 61-75.
17. Morimoto T, Kinouchi Y, Iritani T, Kimura S, Konishi Y, Mitsuyama N, Komaki K, Monden Y. Measurement of the electrical bio-impedance of breast tumors. Eur Surg Res 1990; 22: 86-92.
18. Piperno G, Frei EH, Moshitzky M. Breast cancer screening by impedance measurements. Front Med Biol Eng 1990; 2: 111-117.
19. Malich A, Boehm T, Facius M, Freesmeyer MG, Fleck M, Anderson R, Kaiser WA. Differentiation of mammographically suspicious lesions: evaluation of breast ultrasound, MRI, mammography and electrical impedance scanning as adjunctive technologies in breast cancer detection. Clin Radiol 2001; 56: 278-283.
20. Malich A, Boehm T, Facius M, Freesmeyer MG, Fleck M, Anderson R, Kaiser WA. Additional value of electrical impedance scanning: experience of 240 histologically-proven breast lesions. Eur J Cancer 2001; 37: 2324-2330.
21. Malich A, Fritsch T, Anderson R, Boehm T, Freesmeyer MG, Fleck M, Kaiser WA. Electrical impedance scanning for classifying suspicious breast lesions: first results. Eur Radiol 2000; 10: 1555-1561.
22. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, Wolloch Y, Gal R. Double-phase 99mTc-Sestamibi scintimammography and Trans-Scan in diagnosing breast cancer. J Nucl Med 1999; 40: 376-380.
23. Wersebe A, Siegmann K, Krainick U, Fersis N, Vogel U, Claussen CD, Mueller-Schimpfe M. Diagnostic potential of targeted electrical impedance scanning in classifying suspicious breast lesions. Invest Radiol 2002; 37: 65-72.
24. Scholz B, Anderson R. On electrical impedance scanning - principles and simulations. Electromedica 2000; 68: 35-44.
25. Ultchin Y, Nachaliel U, Ori A. Indirect calculation of breast tissue impedance values. Physiol Meas 2002; 23: 177-182.
26. Fuchsjaeger M, Szabo B, Malich A, Diebold T, Bone B, Helbich T. Differentiation of malignant and benign breast lesions: electrical impedance scanning vs mammography and sonography. RSNA Scientific Paper Session 2001; paper #1333, session #Q06.
27. Fuchsjaeger M, Diebold T, Szabo B, Malich A, Kaiser W, Bone B, Vogel TJ, Helbich T. Adjunctive use of electrical impedance scanning (EIS) new software algorithm to differentiate breast lesions in comparison to histopathology: European multicentre study. ECR Vienna 2002: Presentation B-0649.
28. Glickman YA, Filo O, Nachaliel U, Lenington S, Amin-Spector S, Ginor R. Novel EIS Postprocessing Algorithm for Breast Cancer Diagnosis. IEEE Trans Med Imaging 2002; 21(6): 710-712.
29. Emtestam L, Nicander I, Stenstrom M, Ollmar S. Electrical impedance of nodular basal cell carcinoma: a pilot study. Dermatology 1998; 197: 313-316.
30. Malich A, Fritsch T, Mauch C, Boehm T, Freesmeyer M, Fleck M, Anderson R, Kaiser WA. Electrical impedance scanning: a new technique in the diagnosis of lymph nodes in which malignancy is suspected on ultrasound. Br J Radiol 2001; 74: 42-47.
31. Nicander I, Ollmar S, Eek A, Lundh Rozell B, Emtestam L. Correlation of impedance response patterns to histological findings in irritant skin reactions induced by various surfactants. Br J Dermatol 1996; 134: 221-228.
32. Nicander I, Ollmar S. Electrical bioimpedance related to structural differences and reactions in skin and oral mucosa. Ann N Y Acad Sci 1999; 873: 221-226.
33. Assenheimer M, Laver-Moskovitz O, Malonek D, Manor D, Nachaliel U, Nitzan R, Saad A. The T-Scan™ technology: electrical impedance as a diagnostic tool for breast cancer detection. Physiol Meas 2001; 22: 1-8.
34. Metz CE. Fundamental ROC, analysis. In: Beutel J, Kundel H, Van Metter R, eds. Handbook of Medical Imaging, vol. 1: Physics and Psychophysics. Bellingham, WA: SPIE Press; 2000. p. 751-769.
35. Ackerman AB, Mihara I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol 1985; 16: 87-91.
36. Kelly JW, Crutcher WA, Sagebiel RW. Clinical diagnosis of dysplastic melanocytic nevi. J Am Acad Dermatol 1986; 14: 1044-1052.
37. Piepkorn M, Meyer LJ, Goldgar D, Seuchter SA, Cannon-Albright LA, Skolnick MH, Zone JJ. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989; 20: 407-415.